INTERNATIONAL PATENT: MILTENYI BIOTEC B.V. & CO. KG FILES APPLICATION FOR "CD4- OR CD8-TARGETED RETROVIRAL VECTOR PARTICLES FOR GENERATION OF CELLS EXPRESSING A BISPECIFIC CHIMERIC ANTIGEN RECEPTOR"

GENEVA, Sept. 1 -- MILTENYI BIOTEC B.V. & CO. KG (Friedrich-Ebert-Str. 6851429 Bergisch Gladbach) filed a patent application (PCT/EP2025/054740) for "CD4- OR CD8-TARGETED RETROVIRAL VECTOR PARTICLES FOR GENERATION OF CELLS EXPRESSING A BISPECIFIC CHIMERIC ANTIGEN RECEPTOR" on Feb 21, 2025. With publication no. WO/2025/176853, the details related to the patent application was published on Aug 28, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): CORDES-PAULITZ, Nicole (c/o Miltenyi Biotec B.V. & Co. KGFriedrich-Ebert-Str. 6851429 Bergisch Gladbach), SCHASER, Thomas (c/o Miltenyi Biotec B.V. & C...